Obesity Pillars (Online)
Journal
Overview
publication venue for
-
Corrigendum to "Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings" [Obes. Pillars, Volume 11, September 2024, 100112].
2024
-
Corrigendum to "Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022" [Obes. Pillars 3 (2022) 100032].
2022
-
Special considerations for the child with obesity: An Obesity Medicine Association (OMA) clinical practice statement (CPS) 2024..
11.
2024
-
Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings..
11.
2024
-
Special considerations for the adolescent with obesity: An obesity medicine association (OMA) clinical practice statement (CPS) 2024..
9.
2023
-
Letter to the Editor of ObesityPillars from the Obesity Medicine Fellowship Council..
6.
2023
-
Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023..
6.
2023
-
Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022..
4.
2022
-
Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022..
3.
2022
-
Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022..
3.
2022
-
Obesity pillars roundtable: Obesity and individuals from the Mediterranean region and Middle East..
2.
2022
-
Assessment, differential diagnosis, and initial clinical evaluation of the pediatric patient with obesity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022..
1.
2022
-
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society.
2025
-
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.
2025
-
Clinical review: Guide to pharmacological management in pediatric obesity medicine.
2023
Identity
ISO Abbreviation
Linking ISSN
Electronic International Standard Serial Number (EISSN)